BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30796009)

  • 1. Striatal dopamine activity and myocardial
    Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
    Parkinsonism Relat Disord; 2019 Jun; 63():156-161. PubMed ID: 30796009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
    Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
    Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma α-synuclein with cardiac
    Park DG; Kang J; An YS; Chang J; Yoon JH
    Neurosci Lett; 2022 Jan; 770():136399. PubMed ID: 34921912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-phase
    Kim MS; Park DG; An YS; Yoon JH
    Eur J Neurol; 2023 Feb; 30(2):344-352. PubMed ID: 36288409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.
    Oh YS; Kim JS; Hwang EJ; Lyoo CH
    Parkinsonism Relat Disord; 2018 Nov; 56():47-51. PubMed ID: 29925486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.
    Yoo SW; Oh YS; Hwang EJ; Ryu DW; Lee KS; Lyoo CH; Kim JS
    Neurobiol Dis; 2019 Dec; 132():104563. PubMed ID: 31377233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.
    Ishibashi K; Saito Y; Murayama S; Kanemaru K; Oda K; Ishiwata K; Mizusawa H; Ishii K
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):3-11. PubMed ID: 19626324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender difference in the effect of uric acid on striatal dopamine in early Parkinson's disease.
    Oh YS; Kim JS; Yoo SW; Hwang EJ; Lyoo CH; Lee KS
    Eur J Neurol; 2020 Feb; 27(2):258-264. PubMed ID: 31446637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric symptoms and striatal monoamine availability in early Parkinson's disease without dementia.
    Oh YS; Kim JH; Yoo SW; Hwang EJ; Lyoo CH; Lee KS; Kim JS
    Neurol Sci; 2021 Feb; 42(2):711-718. PubMed ID: 33128104
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
    J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
    Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
    PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W; Kohara S; Hashimoto J
    Clin Neurol Neurosurg; 2017 Sep; 160():73-77. PubMed ID: 28689103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrasubject relationship between striatal 18F-FP-CIT uptake and cardiac 123I-MIBG uptake differs by motor subtype in early Parkinson disease.
    Jang W; Lee JY; Kim JY; Lee SJ; Kim TY; Choi YY; Kim HT; Kim CK
    Medicine (Baltimore); 2021 Aug; 100(33):e26995. PubMed ID: 34414983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
    Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S
    Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of cardiac
    Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
    J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.